CIBC World Market
PACB icon

CIBC World Market’s Pacific Biosciences PACB Stock Holding History

CIBC World Market’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,400
Closed -$15K – 1617
2026
Q1 		$15K Hold
11,400
– – ﹤0.01% 1459
2025
Q4 		$21.3K Sell
11,400
-18,600
-62% -$35.7K ﹤0.01% 1434
2025
Q3 		$38.4K Sell
30,000
-3,100
-9% -$4.2K ﹤0.01% 1396
2025
Q2 		$41K Sell
33,100
-25,000
-43% -$28.9K ﹤0.01% 1336
2025
Q1 		$68.6K Buy
+58,100
New +$89.1K ﹤0.01% 1319
2023
Q1 		– Sell
-10,529
Closed -$86K – 1317
2022
Q4 		$86K Buy
+10,529
New +$90.7K ﹤0.01% 1206

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC World Market's PACB Position: Q2 2026 in Review

CIBC World Market sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 11,400 shares — an estimated $15K sold.

CIBC World Market first reported a position in PACB in Q4 2022 and held it in 6 quarters. The position peaked at $86K in Q4 2022. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • CIBC World Market reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
  • CIBC World Market sold 11,400 Pacific Biosciences shares in Q2 2026, an estimated $15K.
  • CIBC World Market first reported a position in Pacific Biosciences in Q4 2022 and held it in 6 quarters.
  • CIBC World Market's Pacific Biosciences position peaked at $86K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.